US5498088A
(en)
*
|
1992-07-27 |
1996-03-12 |
Choate; John I. M. |
Keyboard arrangement to maximize typing speed and ease of transition from a qwerty keyboard
|
US5352050A
(en)
*
|
1992-07-27 |
1994-10-04 |
Choate John I M |
Keyboard arrangement to maximize typing speed and ease of transition from a QWERTY keyboard
|
US5836705A
(en)
*
|
1992-07-27 |
1998-11-17 |
Choate; John I. M. |
Keyboard arrangement to maximize typing speed and data entry and to ease transition from a qwerty keyboard
|
DK72793D0
(da)
*
|
1993-06-21 |
1993-06-21 |
Novo Nordisk As |
Nyt produkt
|
US5461031A
(en)
*
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
US5474978A
(en)
*
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
US5547929A
(en)
*
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
YU18596A
(sh)
*
|
1995-03-31 |
1998-07-10 |
Eli Lilly And Company |
Analogne formulacije monomernog insulina
|
WO1997002043A1
(en)
*
|
1995-06-30 |
1997-01-23 |
Novo Nordisk A/S |
Prevention of a disease having the characteristics of diabetes
|
CA2258097C
(en)
*
|
1996-06-20 |
2011-02-08 |
Novo Nordisk A/S |
Insulin preparations containing nacl
|
ZA984697B
(en)
*
|
1997-06-13 |
1999-12-01 |
Lilly Co Eli |
Stable insulin formulations.
|
IL134901A0
(en)
|
1997-10-24 |
2001-05-20 |
Lilly Co Eli |
Insoluble insulin compositions
|
CO4970787A1
(es)
*
|
1997-12-23 |
2000-11-07 |
Lilly Co Eli |
Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
|
DE69924232D1
(de)
*
|
1998-01-09 |
2005-04-21 |
Novo Nordisk As |
Stabilisierte insulin-zubereitungen
|
US6635617B1
(en)
|
1998-10-16 |
2003-10-21 |
Novo Nordisk A/S |
Insulin preparations for pulmonary delivery containing menthol
|
US6211144B1
(en)
|
1998-10-16 |
2001-04-03 |
Novo Nordisk A/S |
Stable concentrated insulin preparations for pulmonary delivery
|
DE69901726T2
(de)
*
|
1998-10-16 |
2002-12-19 |
Novo Nordisk As |
Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung
|
BR9914568A
(pt)
*
|
1998-10-16 |
2001-07-03 |
Novo Nordisk As |
Formulação aquosa de insulina, preparação de insulina e método de tratamento de diabetes do tipo i ou do tipo ii
|
US6489292B1
(en)
|
1998-11-18 |
2002-12-03 |
Novo Nordisk A/S |
Stable aqueous insulin preparations without phenol and cresol
|
EP1131089B1
(en)
*
|
1998-11-18 |
2004-02-18 |
Novo Nordisk A/S |
Stable aqueous insulin preparations without phenol and cresol
|
US20040214747A1
(en)
*
|
1999-01-06 |
2004-10-28 |
Dimarchi Richard Dennis |
Method for administering monomeric insulin
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
WO2001052937A1
(en)
|
2000-01-24 |
2001-07-26 |
Medtronic Minimed, Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
EP1383540B1
(en)
*
|
2000-07-31 |
2009-04-29 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
DE10114178A1
(de)
*
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
US6737401B2
(en)
*
|
2001-06-28 |
2004-05-18 |
Metronic Minimed, Inc. |
Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
|
ES2412306T3
(es)
|
2002-01-09 |
2013-07-11 |
Emisphere Technologies, Inc. |
Polimorfos de 4-((4-cloro-2-hidroxibenzoil)amino)butanoato de sodio
|
US20040005999A1
(en)
*
|
2002-03-07 |
2004-01-08 |
Andreasen Kasper Huus |
Polyamino acid-based particle insulin preparation
|
US20030211976A1
(en)
*
|
2002-03-07 |
2003-11-13 |
Andreasen Kasper Huus |
Polyamino acid-based particle insulin formulation
|
DE10227232A1
(de)
*
|
2002-06-18 |
2004-01-15 |
Aventis Pharma Deutschland Gmbh |
Saure Insulinzubereitungen mit verbesserter Stabilität
|
US20060258561A1
(en)
*
|
2003-03-13 |
2006-11-16 |
Novo Nordisk A/S |
Novel NPH insulin preparations
|
JP4864701B2
(ja)
|
2003-06-17 |
2012-02-01 |
セムバイオシス ジェネティクス インコーポレイテッド |
植物におけるインスリンの製造方法
|
DE602004021603D1
(de)
*
|
2003-07-25 |
2009-07-30 |
Conjuchem Biotechnologies Inc |
Insulinderivative mit langanhaltender wirkung und verfahren zu deren herstellung
|
WO2005072803A1
(en)
*
|
2004-01-16 |
2005-08-11 |
Biodel, Inc. |
Sublingual drug delivery device
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
AU2005240213B8
(en)
|
2004-05-06 |
2011-10-20 |
Emisphere Technologies, Inc. |
Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
|
JP4995080B2
(ja)
*
|
2004-05-14 |
2012-08-08 |
エミスフェアー・テクノロジーズ・インク |
活性薬剤を送達するためのアリールケトン化合物および組成物
|
US20080044481A1
(en)
*
|
2004-05-27 |
2008-02-21 |
Mordechai Harel |
Microparticles for Oral Delivery
|
MX2007000883A
(es)
|
2004-07-19 |
2007-04-02 |
Biocon Ltd |
Conjugados de insulina-oligomero, formulaciones y usos de los mismos.
|
EP1773376A4
(en)
|
2004-08-03 |
2009-07-01 |
Emisphere Tech Inc |
ANTIDIBLE ORAL INSULIN BIGUANIDE COMBINATION
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
EP1781257B1
(en)
*
|
2004-08-13 |
2018-12-19 |
Emisphere Technologies, Inc. |
Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
|
ES2544329T3
(es)
*
|
2004-10-05 |
2015-08-28 |
Novo Nordisk A/S |
Una formulación farmacéutica que contiene insulina cristalina e insulina disuelta
|
WO2006053906A1
(en)
|
2004-11-22 |
2006-05-26 |
Novo Nordisk A/S |
Soluble, stable insulin-containing formulations with a protamine salt
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
EP1862174A1
(en)
*
|
2005-03-02 |
2007-12-05 |
Ajinomoto Co., Inc. |
Inhibitor for insulin polymer formation
|
EP1940440A4
(en)
|
2005-08-29 |
2009-11-11 |
Healor Ltd |
METHOD AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETIC AND AGED SKIN
|
JP2009508875A
(ja)
*
|
2005-09-19 |
2009-03-05 |
エミスフェアー・テクノロジーズ・インク |
N−(5−クロロサリチロイル)−8−アミノカプリル酸二ナトリウム塩の結晶形
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7713929B2
(en)
*
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20090069216A1
(en)
*
|
2006-02-21 |
2009-03-12 |
Novo Nordisk A/S |
Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof
|
WO2007121318A2
(en)
|
2006-04-12 |
2007-10-25 |
Emisphere Technologies, Inc. |
Formulations for delivering insulin
|
US7718609B2
(en)
|
2006-04-12 |
2010-05-18 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
EP2074140B8
(en)
|
2006-10-04 |
2015-10-28 |
Case Western Reserve University |
Fibrillation-resistant insulin and insulin analogues
|
EP2134351B1
(en)
|
2007-03-13 |
2016-04-27 |
Nutrition 21, Inc. |
Methods and compositions for the sustained release of chromium
|
WO2008116141A1
(en)
*
|
2007-03-21 |
2008-09-25 |
Emisphere Technologies, Inc. |
Allylqxy and alkyloxy benzoic acid delivery agents
|
EP2514412A1
(en)
*
|
2007-04-30 |
2012-10-24 |
Novo Nordisk A/S |
Highly Concentrated Insulin Solutions and Compositions
|
WO2009002867A2
(en)
|
2007-06-26 |
2008-12-31 |
Nutrition 21, Inc. |
Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
|
US9241908B2
(en)
|
2007-10-16 |
2016-01-26 |
Biocon Limited |
Orally administrable solid pharmaceutical composition and a process thereof
|
PT2215047E
(pt)
|
2007-11-02 |
2014-01-20 |
Emisphere Tech Inc |
Processo para o tratamento da deficiência de vitamina b12
|
JP5780958B2
(ja)
|
2008-07-31 |
2015-09-16 |
ケイス、ウエスタン、リザーブ、ユニバーシティ |
ハロゲン安定化インスリン
|
JP2012502048A
(ja)
|
2008-09-08 |
2012-01-26 |
ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法
|
RS59913B1
(sr)
|
2008-10-17 |
2020-03-31 |
Sanofi Aventis Deutschland |
Kombinacija insulina i glp-1-agonista
|
US8389522B2
(en)
|
2008-10-28 |
2013-03-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase and methods of use thereof
|
MA33064B1
(fr)
|
2009-01-28 |
2012-02-01 |
Smartcells Inc |
Systemes à base de conjugués pour administration contrôlée de médicaments
|
AU2010208305A1
(en)
|
2009-01-28 |
2011-09-08 |
Smartcells, Inc. |
Synthetic conjugates and uses thereof
|
ES2493618T3
(es)
|
2009-02-12 |
2014-09-12 |
Proyecto De Biomedicina Cima, S.L. |
Uso de la cardiotrofina-1 para el tratamiento de enfermedades metabólicas
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
CA2754950A1
(en)
|
2009-03-20 |
2010-09-23 |
Smartcells, Inc. |
Terminally-functionalized conjugates and uses thereof
|
ES2534191T3
(es)
|
2009-11-13 |
2015-04-20 |
Sanofi-Aventis Deutschland Gmbh |
Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
|
KR101337322B1
(ko)
|
2009-11-13 |
2013-12-06 |
사노피-아벤티스 도이칠란트 게엠베하 |
Glp-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
|
RU2012133148A
(ru)
|
2010-01-11 |
2014-02-20 |
Хилор Лтд. |
Способ лечения воспалительного заболевания и расстройства
|
AU2011220867B2
(en)
*
|
2010-02-24 |
2014-05-15 |
Emisphere Technologies, Inc. |
Oral B12 therapy
|
BR112013004756B1
(pt)
|
2010-08-30 |
2020-04-28 |
Sanofi Aventis Deutschland |
uso de ave0010 para a fabricação de um medicamento para o tratamento da diabetes melito tipo 2
|
EP2621911A1
(en)
|
2010-09-30 |
2013-08-07 |
Solvay Sa |
Derivative of epichlorohydrin of natural origin
|
WO2012115641A1
(en)
|
2011-02-23 |
2012-08-30 |
Elona Biotechnologies |
Lis-pro proinsulin compositions and methods of producing lis-pro insulin analogs therefrom
|
EP2680861B1
(en)
|
2011-03-01 |
2022-05-04 |
Nutrition 21, LLC |
Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
|
US10457659B2
(en)
|
2011-04-29 |
2019-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
PL2750699T3
(pl)
|
2011-08-29 |
2015-12-31 |
Sanofi Aventis Deutschland |
Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
|
TWI559929B
(en)
|
2011-09-01 |
2016-12-01 |
Sanofi Aventis Deutschland |
Pharmaceutical composition for use in the treatment of a neurodegenerative disease
|
US9908925B2
(en)
|
2011-10-27 |
2018-03-06 |
Case Western Reserve University |
Ultra-concentrated rapid-acting insulin analogue formulations
|
WO2014004278A1
(en)
*
|
2012-06-26 |
2014-01-03 |
The Curators Of The University Of Missouri |
Photocleavable drug conjugates
|
WO2014015078A1
(en)
|
2012-07-17 |
2014-01-23 |
Michael Weiss |
O-linked carbohydrate-modified insulin analogues
|
EP3332810B1
(fr)
|
2012-11-13 |
2021-01-13 |
Adocia |
Formulation à action rapide d'insuline comprenant un composé anionique substitué
|
EP2925345B1
(en)
|
2012-12-03 |
2018-09-05 |
Merck Sharp & Dohme Corp. |
Method for making o-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
|
JP6111475B2
(ja)
|
2012-12-19 |
2017-04-12 |
ウォックハート リミテッド |
ヒトインスリン又はその類似体もしくは誘導体を含む安定な水性組成物
|
MX2015006997A
(es)
|
2012-12-26 |
2015-09-23 |
Wockhardt Ltd |
Composicion farmaceutica.
|
WO2014160185A2
(en)
|
2013-03-14 |
2014-10-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
|
TW201605489A
(zh)
|
2013-10-25 |
2016-02-16 |
賽諾菲公司 |
賴谷胰島素(insulin glulisine)的穩定調配物
|
EP3185887B1
(en)
|
2014-08-26 |
2021-03-10 |
Merck Sharp & Dohme Corp. |
Method for preparing crystalline insulin or insulin analog compositions
|
HRP20230470T1
(hr)
|
2014-12-12 |
2023-07-21 |
Sanofi-Aventis Deutschland Gmbh |
Formulacija fiksnog omjera inzulin glargin/liksisenatid
|
AR102869A1
(es)
|
2014-12-16 |
2017-03-29 |
Lilly Co Eli |
Composiciones de insulina de rápida acción
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患治療
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患之治療
|
JO3749B1
(ar)
|
2015-08-27 |
2021-01-31 |
Lilly Co Eli |
تركيبات إنسولين سريعة المفعول
|
MX2018009748A
(es)
|
2016-02-11 |
2019-02-07 |
Nutrition 21 Llc |
Composiciones que contienen cromo para mejorar la salud y el estado físico.
|
WO2018222787A1
(en)
|
2017-06-01 |
2018-12-06 |
Eli Lilly And Company |
Rapid-acting insulin compositions
|
US11820805B2
(en)
|
2017-12-18 |
2023-11-21 |
Merck Sharp & Dohme Llc |
Conjugate based systems for controlled insulin delivery
|
EP3740212A4
(en)
|
2017-12-18 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
CONJUGATE-BASED SYSTEMS FOR CONTROLLED INSULIN DELIVERY
|
KR20220115927A
(ko)
|
2019-10-25 |
2022-08-19 |
세르카코르 래버러토리즈, 인크. |
지표 화합물, 지표 화합물을 포함하는 장치, 및 이의 제조 및 사용 방법
|
KR20220161422A
(ko)
|
2020-03-31 |
2022-12-06 |
프로토머 테크놀로지스 인크. |
비시날 디올에 대한 선택적인 반응을 위한 접합체
|
JP2024500284A
(ja)
|
2020-11-19 |
2024-01-09 |
プロトマー・テクノロジーズ・インコーポレイテッド |
芳香族ホウ素含有化合物及びインスリン類似体
|
WO2023225534A1
(en)
|
2022-05-18 |
2023-11-23 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and related insulin analogs
|